News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Reine Allan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2023 |
4
| Reine Allan (CFO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $8.38, valued at
$754.2k
|
|
| 01/28/2022 |
4
| Reine Allan (CFO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 135,000 options to buy
@ $14.87, valued at
$2M
|
|
| 08/11/2021 |
4
| Reine Allan (CFO) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Exercised 26,892 options to buy
@ $3.72, valued at
$100k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2020 |
3
| Reine Allan (CFO) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 02/26/2018 |
4
| Reine Allan (CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 53,833 options to buy
@ $8.56, valued at
$460.8k
Granted 50,000 options to buy
@ $5, valued at
$250k
|
|
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|